Human trial / 2019
Bremelanotide for HSDD: two randomized phase 3 trials
Bremelanotide for HSDD: two randomized phase 3 trials — PubMed (2019), cited in PeptideAgent's PT-141 / Bremelanotide evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- PubMed
- Evidence type
- Human trial
- Publication year
- 2019
- Source ID
- pmid-31599840
WHERE THIS IS CITED